Trademark: 97576821
Word
MV MYVI
Status Date
Wednesday, April 10, 2024
Filing Date
Friday, September 2, 2022
Published for Opposition
Tuesday, March 12, 2024
5 Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, headaches, migraines, pain, immune and inflammatory disorders and diseases; Diagnostic preparations, substances, reagents and agents for medical purposes
45 Providing personal support services for patients receiving treatment of medical disorders in the nature of companionship, help with medical forms, emotional counseling, and emotional support
44 Medical services; clinical services, namely, clinical medical consultation services; therapeutic services, namely, mental health therapy services; healthcare; providing medical and healthcare information; providing medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; providing information about mental health therapy; medical services in the fields of psychiatry, psychology, neurology, and central nervous system diseases and disorders; medical and pharmaceutical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and neurology disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment, and prevention; providing medical information on-line to patients and clients regarding medical dosages, diagnoses, therapeutic issues and selfmanagement of medical issues; providing medical information to medical professionals and patients relating to the prevention, management, and treatment of headaches, migraines, pain, immune and inflammatory disorders, and neurological disorders and diseases via a website
The mark consists of the outline of a chevron composed of a stylized "M" in orange above a stylized "V" in blue, to the left of the stylized wording "MYVI" in blue.
MV MY VI
The colors orange and blue are claimed as a feature of the mark.
Apr 10, 2024
Extension Of Time To Oppose Received
Mar 22, 2024
Teas Change Of Correspondence Received
Mar 22, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 22, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 5, 2024
Approved For Pub - Principal Register
Feb 5, 2024
Teas/Email Correspondence Entered
Feb 5, 2024
Correspondence Received In Law Office
Feb 5, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2024
Assigned To Lie
Sep 12, 2023
Teas Response To Office Action Received
Sep 11, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 11, 2023
Teas Change Of Correspondence Received
Sep 11, 2023
Teas Withdrawal As Domestic Representative Received
Sep 11, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 11, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 13, 2023
Notification Of Non-Final Action E-Mailed
Jun 13, 2023
Non-Final Action E-Mailed
Jun 13, 2023
Non-Final Action Written
Jun 8, 2023
Assigned To Examiner
Sep 22, 2022
Notice Of Design Search Code E-Mailed
Sep 21, 2022
New Application Office Supplied Data Entered
Sep 6, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
